跳至主要内容
临床试验/PACTR201712002760250
PACTR201712002760250尚未招募未知

Partnership for Research on Ebola VACcination (PREVAC)

ational Institute of Allergy and Infectious Diseases (NIAID)0 个研究点目标入组 2,800 人开始时间: 2017年11月13日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
2,800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Year(s) 至 99 Year(s)(—)
性别
All

入选标准

  • ¿ Informed consent/assent
  • ¿ Age greater than or equal to 1 year
  • ¿ Planned residency in the area of the study site for the next 12 months
  • ¿ Willingness to comply with the protocol requirements

排除标准

  • ¿ Fever > 38º Celsius
  • ¿ History of EVD (self-report)
  • ¿ Pregnancy (a negative urine pregnancy test is required for females of child-bearing potential, i.e., females who have experienced menarche or who are aged 14 years and older)
  • ¿ Positive HIV test for participants < 18 years of age
  • ¿ Reported current breast-feeding
  • ¿ Prior vaccination against Ebola (self-report)
  • ¿ Any vaccination in the past 28 days or planned within the 28 days after randomization (initial vaccination)
  • ¿ In the judgement of the clinician, any clinically significant acute/chronic condition that would limit the ability of the participant to meet the requirements of the study protocol

研究者

发起方
ational Institute of Allergy and Infectious Diseases (NIAID)

相似试验